A group of UQ neuroscientists is about to embark upon one of Australia’s biggest studies into the relationship between genes and children with Attention Deficit Hyperactivity Disorder (ADHD). In a national study of more than 600 families led by Associate Professor Mark Bellgrove at the Queensland... 

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has decided to withdraw the European Marketing Authorization Application (MAA) for DAYTRANA(TM) (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).... 

The probability of having one’s child receive an attention deficit hyperactivity disorder (ADHD) diagnosis involves a mother’s own medical conditions and her use of health services prior to having the child, a new study finds. What is not clear, however, is whether the effects are due to... 

In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to a new study by researchers at the National Institutes of Health (NIH) and Duke University... 

Stimulant medications like those often prescribed for children with attention deficit hyperactivity disorder (ADHD) raise blood pressure and heart rate, and some drugs carry warning labels for patients with heart problems. Two professional organizations are at odds over whether routine electrocardiogram... 

Two thirds of primary school teachers struggle to understand and manage attention deficit hyperactivity disorder (ADHD) behaviour because of a lack of training, new research shows. The study, presented at the annual conference of Royal College of Psychiatrists’ Faculty of Child and Adolescent Psychiatry,... 

A drug that diminishes the body’s hyper-reactivity to stress has been shown to significantly reduce symptoms of attention-deficit hyperactivity disorder (ADHD) in children, according to a phase 3 clinical trial conducted by Addrenex Pharmaceuticals. The study showed that the new drug, Clonicel,... 

Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that VYVANSE is now available in U.S. pharmacies nationwide in three additional dosage strengths, bringing the total number to six: 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. The expanded VYVANSE... 

Does your child have frequent temper tantrums? Are they always fidgeting, running around screaming or falling over? Perhaps you teach a child like that. If so, the chances are there’s nothing to worry about and they are just being boisterous. But for five to ten percent of children it isn’t... 

A significant number of adults with unresolved depression, anxiety or addiction may actually have Attention Deficit Hyperactivity Disorder (ADHD), a condition that has been widely considered to resolve in late adolescence. Armed with the correct diagnosis, adult ADHD sufferers could soon be prescribed...